About Us Portfolio Press Careers Sitemap Advertise Contact Us Make this your Homepage

Custom Search

Register

Sign In

Sign In Using Facebook

Home » Research News

'Maintenance Therapy','Doesn't Work' for Advanced Hepatitis C

by Hannah Punitha on December 05, 2008 at 1:38 PM Research News

Researchers from Saint Louis University have revealed that 'maintenance therapy' involving low-dose peginterferon has been found ineffective in patients with advanced hepatitis C.

Related Links

Instead, the study showed that low-dose peginterferon maintenance therapy led to health decline in patients with liver disease over the course of four years.

"This course of treatment had been adopted by a number of doctors in the U.S. and in other countries, though it had yet to be proven to work.

That practice should be stopped based on the results of this trial. There is no rationale for using maintenance therapy," said Adrian Di Bisceglie, M.D., professor of internal medicine, chief of hepatology and co-director of the Liver Center at Saint Louis University.

"The treatment is clearly ineffective," he added.

For patients with chronic hepatitis C, the prognosis varies. About half fully recover after an initial course of peginterferon and ribavirin anti-viral therapy that may last from six months to a year.

The remaining patients, known as non-responders, may improve but the virus is not eliminated.

During the study, the researchers looked at 1050 patients at 10 different clinical sites.

They gave patients peginterferon for three and a half years, but in lower doses to try to suppress but not eliminate the virus, with the hope of slowing the dire consequences of liver disease.

Half of the patients were treated with a low dose of peginterferon and half were put into a control group for a total of four years.

Page 1

Page 1 | 2

Next

Female Arts Students 'Most Likely To Be Sexually Active�

Childhood Obesity Can Damage Thyroid

More News on: Hepatitis A, Hepatitis B, Silent Killer Diseases, Liver, Vasculitis , Aplastic Anemia, Hepatitis C

Comment & Contribute

Be the first to comment!
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters
	Notify me when reply is posted I agree to the terms and conditions
Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished. Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Medwonders Health Network

Support Groups Members Discussions

Total Members - 54894
Support Groups - 445

Health News Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Latest News Most Popular Most Commented

Research Suggests Red Wine Alone may Not be the Elixir of Life

Babies' Health may be Compromised by the 'Too Posh to Push' Attitude

Research Sheds Light on Usefulness of Bubble-Propelled Microrockets

Broken Bones may be Fixed in Less Than 4 Weeks by 'Fracture Putty'

AIDS Drug Venture in South Africa Worth $208 Million

News Archive
Date :
Category :
Keyword :

News Quick Links

	News Central			Health Watch
	Latest Health News			Health In Focus
	News Category (500+)			Breaking Health News
	Popular News			Celebrating Life
	Health News and Press Release			Medindia - Exclusive
	News Photo Gallery			India Special
	News Video Gallery			Lifestyle and Wellness
	News From Other Resources

Hepatitis C

Complete Medindia Resources

News Categories:


»	Research Says Financial Burden of Prescription Drugs is Dropping

»	New Guidelines to Avoid Heparin Contamination

»	Weight Loss Drug Has Killed At Least 1,300 in France

»	FDA Approves Sanofi�s Treatment for Head Lice

»	New Scoring Method may Help Decide Who Will Benefit From Stroke Drug
More Drug News

Research Related News
»	Research Sheds Light on Usefulness of Bubble-Propelled Microrockets	»	Research Details How Deadly Bird Parasite Evolves at a Fast Rate
»	Peptides That Could Lead to Universal Influenza Vaccine Identified	»	Video-Based Home Exercise Able to Ease Osteoarthritis Pain and Perk Up Mobility
»	Memory Enhancement by Stimulating Key Spot in Brain	»	Substance P Causes Seizures in People With Pork Tapeworm
»	Neighboring 'Finger Nerve Cells' Render Middle Finger Slowest	»	Higher Death Rate Observed in Cirrhosis Patients Losing Muscle Mass

Read More >>

Accident and Trauma Care Support Group	Acupuncture Support Group	Albinism / Hypopigmentation / Albinos Support Group
Alcohol abuse / Alcohol dependence / Alcoholism Support Group	Aromatherapy Support Group	Avian Influenza / Bird Flu Support Group
Ayurveda Support Group	Benign Prostatic Hyperplasia Support Group	Birth Defects - Metabolic Defects Support Group

'Maintenance Therapy','Doesn't Work' for Advanced Hepatitis C

Medwonders Health Network

Research Related News

Consumers

Medical Professionals

Medical Students

Directories